vs
FIRST FINANCIAL BANCORP（FFBC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
FIRST FINANCIAL BANCORP的季度营收约是REPLIGEN CORP的1.4倍（$271.5M vs $197.9M），FIRST FINANCIAL BANCORP净利率更高（27.4% vs 6.7%，领先20.7%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 12.4%）
第一金融银行集团是总部位于美国俄亥俄州辛辛那提的区域性银行，运营中心设于辛辛那提北郊斯普林代尔及印第安纳州格林斯堡。该行成立于1863年，拥有美国第六悠久的国家银行牌照，在俄亥俄、印第安纳、肯塔基、伊利诺伊四州共设有131个营业网点，2009年9月曾在政府协助下收购欧文金融公司及其子公司。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FFBC vs RGEN — 直观对比
营收规模更大
FFBC
是对方的1.4倍
$197.9M
净利率更高
FFBC
高出20.7%
6.7%
两年增速更快
RGEN
近两年复合增速
12.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $271.5M | $197.9M |
| 净利润 | $74.4M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 27.4% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.71 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FFBCRGEN
| Q1 26 | $271.5M | — | ||
| Q4 25 | $238.8M | $197.9M | ||
| Q3 25 | $234.0M | $188.8M | ||
| Q2 25 | $226.3M | $182.4M | ||
| Q1 25 | $200.4M | $169.2M | ||
| Q4 24 | $224.3M | $174.1M | ||
| Q3 24 | $201.3M | $154.9M | ||
| Q2 24 | $214.8M | $154.1M |
净利润FFBCRGEN
| Q1 26 | $74.4M | — | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $71.9M | $14.9M | ||
| Q2 25 | $70.0M | $14.9M | ||
| Q1 25 | $51.3M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $52.5M | $-654.0K | ||
| Q2 24 | $60.8M | $3.3M |
毛利率FFBCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率FFBCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 9.0% | ||
| Q3 25 | 38.7% | 8.9% | ||
| Q2 25 | 38.8% | 7.6% | ||
| Q1 25 | 31.7% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | 32.2% | -5.1% | ||
| Q2 24 | 34.8% | 1.0% |
净利率FFBCRGEN
| Q1 26 | 27.4% | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | 30.7% | 7.9% | ||
| Q2 25 | 30.9% | 8.2% | ||
| Q1 25 | 25.6% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 26.1% | -0.4% | ||
| Q2 24 | 28.3% | 2.2% |
每股收益（稀释后）FFBCRGEN
| Q1 26 | $0.71 | — | ||
| Q4 25 | $0.64 | $0.24 | ||
| Q3 25 | $0.75 | $0.26 | ||
| Q2 25 | $0.73 | $0.26 | ||
| Q1 25 | $0.54 | $0.10 | ||
| Q4 24 | $0.68 | $-0.55 | ||
| Q3 24 | $0.55 | $-0.01 | ||
| Q2 24 | $0.64 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $13.1M | $542.2M |
| 股东权益账面价值 | $2.9B | $2.1B |
| 总资产 | $22.5B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FFBCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务FFBCRGEN
| Q1 26 | $13.1M | — | ||
| Q4 25 | $514.1M | $542.2M | ||
| Q3 25 | $221.8M | $537.9M | ||
| Q2 25 | $345.0M | — | ||
| Q1 25 | $345.9M | — | ||
| Q4 24 | $347.5M | $525.6M | ||
| Q3 24 | $344.1M | — | ||
| Q2 24 | $338.6M | — |
股东权益FFBCRGEN
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.8B | $2.1B | ||
| Q3 25 | $2.6B | $2.1B | ||
| Q2 25 | $2.6B | $2.1B | ||
| Q1 25 | $2.5B | $2.0B | ||
| Q4 24 | $2.4B | $2.0B | ||
| Q3 24 | $2.5B | $2.0B | ||
| Q2 24 | $2.3B | $2.0B |
总资产FFBCRGEN
| Q1 26 | $22.5B | — | ||
| Q4 25 | $21.1B | $2.9B | ||
| Q3 25 | $18.6B | $2.9B | ||
| Q2 25 | $18.6B | $2.9B | ||
| Q1 25 | $18.5B | $2.9B | ||
| Q4 24 | $18.6B | $2.8B | ||
| Q3 24 | $18.1B | $2.8B | ||
| Q2 24 | $18.2B | $2.9B |
负债/权益比FFBCRGEN
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.19× | 0.26× | ||
| Q3 25 | 0.08× | 0.26× | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 0.14× | 0.27× | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流FFBCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $337.9M | $25.7M | ||
| Q3 25 | $89.8M | $48.1M | ||
| Q2 25 | $69.8M | $28.6M | ||
| Q1 25 | $56.1M | $15.0M | ||
| Q4 24 | $262.2M | $39.2M | ||
| Q3 24 | $88.1M | $49.3M | ||
| Q2 24 | $68.1M | $42.2M |
自由现金流FFBCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $317.1M | $17.6M | ||
| Q3 25 | $85.8M | $43.4M | ||
| Q2 25 | $64.8M | $21.5M | ||
| Q1 25 | $52.4M | $11.4M | ||
| Q4 24 | $241.1M | $33.6M | ||
| Q3 24 | $84.4M | $42.3M | ||
| Q2 24 | $64.8M | $37.4M |
自由现金流率FFBCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 132.8% | 8.9% | ||
| Q3 25 | 36.7% | 23.0% | ||
| Q2 25 | 28.6% | 11.8% | ||
| Q1 25 | 26.1% | 6.8% | ||
| Q4 24 | 107.5% | 19.3% | ||
| Q3 24 | 42.0% | 27.3% | ||
| Q2 24 | 30.2% | 24.3% |
资本支出强度FFBCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 8.7% | 4.1% | ||
| Q3 25 | 1.7% | 2.5% | ||
| Q2 25 | 2.2% | 3.9% | ||
| Q1 25 | 1.9% | 2.1% | ||
| Q4 24 | 9.4% | 3.2% | ||
| Q3 24 | 1.8% | 4.5% | ||
| Q2 24 | 1.5% | 3.1% |
现金转化率FFBCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.25× | 3.23× | ||
| Q2 25 | 1.00× | 1.92× | ||
| Q1 25 | 1.09× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | 1.12× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FFBC
| Net Interest Income | $189.6M | 70% |
| Noninterest Income | $81.9M | 30% |
RGEN
暂无分部数据
